Ahmedabad (Gujarat) [India], July 4 (ANI): Union Minister of State for Chemicals and Fertilisers Mansukh Mandaviya on Sunday visited the COVID-19 vaccine manufacturing facilities of Zydus Cadila and Hester Biosciences in Gujarat.
Bengaluru (Karnataka) [India], July 4 (ANI): Karnataka can only be saved from the likely third wave of COVID if 80 per cent of its adult population is vaccinated with both COVID-19 vaccine doses by the end of September, said Congress leader DK Shivakumar on Sunday.
Asansol (West Bengal) [India], July 4 (ANI): Former deputy mayor of Asansol Municipal Corporation and TMC leader Tabassum Ara on Saturday landed in controversies after she allegedly administered COVID-19 vaccine to an individual.
Moscow [Russia], July 3 (ANI): Coronavirus vaccines remain effective in spite of the virus mutations, said an official of the St. Petersburg Pasteur Institute of Epidemiology and Microbiology on Friday.
Tokyo [Japan], July 3 (ANI): Aiming to curb Chinese expansionism jointly with the US, Japan has urged leaders from Pacific island nations to unite against the authoritarianism of China by promising COVID-19 vaccine doses and economic assistance to the region.
New Delhi [India], July 3 (ANI): Bollywood actor Shilpa Shetty joined the clan of celebrities who have taken the second jab of the COVID-19 vaccine by receiving the second shot on Saturday.
Washington [US], July 3 (ANI): An international team of researchers with a recent survey found that nearly all patients with cancer developed a good immune response to the COVID-19 mRNA vaccines three to four weeks after receiving their second dose.
New Delhi [India], July 3 (ANI): A Lancet report published recently suggests that flexible, agile vaccination strategies could play an important part in protecting lives and livelihoods as the COVID-19 pandemic continues to unfold.
New Delhi [India], July 3 (ANI): As many 44,111 new COVID-19 cases and 738 deaths were reported in India in the last 24 hours, said the Ministry of Health and Family Welfare on Saturday.
Hyderabad (Telangana) [India], July 3 (ANI): Hyderabad-based Bharat Biotech on Saturday concluded a final analysis for its vaccine Covaxin efficacy from phase-3 clinical trial claiming it to be 77.8 per cent effective against COVID-19.